DXR - Daxor Corporation logo

Daxor Corporation

DXR

Daxor Corporation develops medical instruments focused on blood volume measurement, including the BVA-100 Blood Volume Analyzer and diagnostic kits for heart failure. Its services cater to hospitals and critical care facilities, enhancing patient management.

โš•๏ธ Healthcare NASDAQ Listed 1992 $ USD
$1,000 invested 30 years ago โ†’$1,222today

Score Overview

1 Year
Score
Net Growth17x
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-76.37%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score7.6
Net Growth7x
Net Trend80%
Net Income Consistencyโ€”
Rev Growth150.53%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth200.26%
Net Trend70%
Net Income Consistency
Rev Growth106.76%
Rev Trend60%
Revenue Consistency
20 Years
Score3.8
Net Growth8x
Net Trend60%
Net Income Consistency
Rev Growth-62.53%
Rev Trend45%
Revenue Consistency
30 Years
Score
Net Growth7x
Net Trend53%
Net Income Consistency
Rev Growth-89.29%
Rev Trend50%
Revenue Consistency
All Time
Score
Net Growth169.70%
Net Trend48%
Net Income Consistency
Rev Growth-91.75%
Rev Trend48%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Daxor Corporation has ranked, year by year

Measure
Fundamentals Window

Showing 5 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • DXR

1998: 100.0% ยท 2021: 43.6% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 11.35โ€”
1 Year2025-09-26
$ 12.05-5.81%
5 Years2021-09-28
$ 11.032.89%
10 Years2016-09-27
$ 7.8045.43%
20 Years2006-09-28
$ 11.39-0.36%
30 Years1996-09-27
$ 9.2922.16%
All Time1992-03-17
$ 1.766x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
2025$ 503.42K$ 9M
2024$ 2M$ 536.33K
2023$ 34M$ 280.64K
2022$ 6M$ 5M
2021$ 5M$ 4M$ 710.7K
2020-$ 996.3K-$ 1M$ 617.8K
2019-$ 114.99K-$ 495.7K
2018-$ 918.45K-$ 885.77K
2017-$ 1M-$ 1M$ 1M
2016$ 1M$ 1M$ 2M
2015-$ 7M-$ 9M$ 2M
2014-$ 4M-$ 976.7K
2013-$ 11M-$ 8M
2012-$ 2M$ 1M
2011$ 1M-$ 7M$ 59.63K
2010$ 1M$ 4M$ 57.74K
2009$ 1M$ 5M$ 277.09K
2008$ 1M$ 15M$ 2M
2007$ 1M$ 10M$ 2M
2006$ 1M-$ 785.53K$ 2M
2005$ 1M-$ 1M$ 93K
2004$ 1M-$ 580.27K$ 5.08K
2003$ 3M-$ 1M$ 3.32K
2002$ 2M-$ 193.85K$ 13.04K
2001$ 758.37K$ 299.36K$ 431.95K
2000$ 745.79K-$ 55.19K$ 18.44K
1999$ 575.38K-$ 97.15K$ 67.78K
1998$ 300K-$ 400K$ 100K
1997$ 500K-$ 200K$ 100K
1996$ 2M-$ 100K$ 100K
1995$ 4M$ 1M$ 100K
1994$ 4M$ 1M$ 100K
1993$ 4M$ 2M$ 300K
IPO1992$ 6M$ 3M$ 200K
DXR - Daxor Corporation logo

Daxor Corporation fundamental performance

Between 2020 and 2025, revenue went from -$ 996.3K to $ 503.42K and net income went from -$ 1M to $ 9M. Revenue increased in 3 of those 5 years; net income in 4.

Between 2015 and 2025, revenue went from -$ 7M to $ 503.42K and net income went from -$ 9M to $ 9M. Revenue increased in 6 of those 10 years; net income in 7.

Daxor Corporation currently holds a 20-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.

Membership

Continue DXRโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies